Translational Development Acquisition Units (TDACU) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 11 27 sessions, July 23, 2025 to July 28, 2026
- Largest daily move
- +65.6% close of May 26, 2026
- 1-year change
- +20.7% closing prices, July 23, 2025 to July 28, 2026
- 5-year change
- +0.7% closing prices, July 27, 2021 to July 28, 2026
Company Description
Translational Development Acquisition Units (NASDAQ: TDACU) is classified in the shell companies industry within the Financial Services sector.
TDACU has gained 20.7% over the past year. The last closing price was $12.57.
For FY2025, Translational Development Acquisition Units reported net income of $6.4M.
This page collects what Stock Titan holds for TDACU, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Translational Development Acquisition Units (TDACU) closed at $12.57 on July 28, 2026. Over the past 12 months, the price has gained 20.7%.
TDACU Metrics & Rankings
Price returns through July 28, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Translational Development Acquisition Units has 10 recent news articles. Of the recent coverage, 8 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all TDACU news →
SEC Filings
Translational Development Acquisition Units has filed 5 recent SEC filings, including 2 Form SCHEDULE 13G/A, 1 Form 10-Q, 1 Form SCHEDULE 13G, 1 Form 8-K. The most recent filing was submitted on August 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TDACU SEC filings →
Financial Highlights
operating income reached -$945K, and net income was $6.4M. The company generated -$608K in operating cash flow. With a current ratio of 0.07, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Translational Development Acquisition Units (TDACU) currently stands at 3 shares. Since November 2025, short interest has increased by 200.0%.
Days to Cover History
Days to cover for Translational Development Acquisition Units (TDACU) currently stands at 3.0 days, up 200% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 200% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 3.0 days.
TDACU Company Profile & Sector Positioning
Translational Development Acquisition Units (TDACU) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing TDACU often look at related companies in the same sector, including Bold Eagle Acquisition Corp. Units (BEAGU), Aldel Financial II Inc. Units (ALDFU), Cayson Acquisition Corp Unit (CAPNU), Charlton Aria Acquisition Corporation Units (CHARU), and Future Vision II Acquisition Corporation Units (FVNNU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TDACU's relative position within its industry.